lesions. Total tubular damage scores ranged from 0 to 25 and the LI/Tub ranged from 0 to 3-68% in all 23 biopsy specimens. Analyses of variance showed highly significant correlations between the total tubular damage score and both LI/Tub ( p = 0 004) and LI/PCT (p = 0.004); a weaker correlation was found between the total tubular damage score and LI/DCT (p = 0-013). Conclusions-A correlation was found between tubular damage and BrdU LI. This was most clearly seen in the proximal tubules. However, as the study was limited to a few examples of specific forms of glomerular or interstitial disease, firm conclusions about the value of BrdU labelling in routine diagnosis and prognosis could not be drawn.
Abstract
Aims-To exaine the correlation between bromodeoxyuridine (BrdU) labelling indices (LI) and tubular damage in renal biopsy specimens; to evaluate the diagnostic and prognostic potential of measuring cell proliferation in a variety of renal lesions. Methods-In vitro BrdU labelling of renal biopsy specimens was undertaken and labelled cells were detected in routinely fixed, paraffin wax embedded sections by inumunohistochemistry. The BrdU LI were calculated as percentages for the three types of tubular cellsproximal and distal convoluted tubules and medulla (LIIPCT, LIVDCT, LIIMed)-and a total tubular BrdU LI (LI/Tub) was also calculated for each biopsy specimen. Histological features indicative of tubular damage were also scored and a total tubular damage score obtained for each biopsy specimen. Results 
Methods
Needle biopsy specimens, 1-8 mm in diameter, were obtained from renal patients in the Royal Infirmary, Sunderland, and Freeman Hospital, Newcastle upon Tyne. All patients were undergoing biopsy for diagnostic purposes.
The labelling medium was RPMI 1640, supplemented with penicillin/streptomycin solution at 100 U/ml/100 ,ug/ml, HEPES buffer (pH 7 3) at 20 mM, and L-glutamine at 2 mM. The osmolality of the medium was adjusted to 290 mosmol/kg with sterile distilled water. Aliquots (1.93 ml) were stored for up to one week at 4°C in sterile, capped, plastic tubes.
Immediately before use, 10 pul each of BrdU and hydrogen peroxide solutions were added to each aliquot to give final concentrations of 10 ,uM and 0-015%, respectively.
It was essential that all renal cores be incubated as soon as possible after biopsy. We therefore designed and constructed a portable, rechargeable, battery operated, aluminium incubation block ( fig 1) . The block was designed to require the minimum of attention from the clinician or radiologist performing the biopsy. The incubation block was constructed around a 25 mm x 50 mm x 50 mm aluminium block with two holes (15 mm in diameter, 35 mm deep) in the top surface to accommodate the tubes containing the biopsy specimen in labelling medium. The temperature of the medium was maintained at 370C by two resistors (4 7 Q 25 W) fixed to the block, and powered by four rechargeable cells ("D" size 1 25 V). The temperature was controlled by a thermistor inserted into the centre of the block and a LM324 op-amp switching the two resistors through a TIP3055 power switching transistor. The rechargeable cells have a capacity of four amp hours giving at least two hours' use of the incubation block. In practice, the block operates satisfactorily for up to six hours between charges.
Immediately after biopsy, each renal core was placed in 1-95 ml labelling medium containing BrdU and hydrogen peroxide, prewarmed to 370C in the incubation block. Incubation was continued for one hour, during which time the block containing the specimen was taken to the histopathology laboratory.
After labelling, biopsy specimens were placed into sterile 0 01 M phosphate buffered saline (PBS), pH 7-2, for routine processing and diagnosis. Samples of each biopsy core were taken for immunofluorescence and electron microscopy and the remainder was fixed in formal sublimate for 45 minutes at room temperature. After fixation, the biopsy specimens were transferred to 70% ethanol, before processing and embedding in paraffin wax (560C). Sections, at 2 to 4 um, on lysine coated slides, were prepared for routine histology and for the detection of BrdU labelled cells.
Histological assessment of each biopsy specimen was made from sections stained with periodic acid Schiff (PAS) or eosin and Mayer's haematoxylin. All sections were coded and read blind. Fourteen features indicative of tubular damage (table 1) In vitro BrdU labelling of renal biopsy specimens labelling index (LI/Tub) was also calculated for each biopsy specimen by summating the counts from the three types of cells. All measurements were determined with coded slides. Analysis of variance was used as detailed.
Results
Twenty three renal biopsy specimens from 22 patients were labelled in vitro with BrdU before routine processing. The one hour labelling process did not affect tissue mor- phology in any of the biopsy specimens and, hence, did not impede subsequent diagnosis of the renal lesion. The histological diagnoses of the 23 biopsy specimens are given in table 2, together with the total tubular damage scores and the BrdU LIs. Eight of the specimens did not contain any medulla.
Four biopsy specimens (cases 8, 25, 26, 27) were obtained from three renal transplant recipients. Two consecutive biopsy specimens were obtained from one transplant recipient: the first (case 8) was taken during a rejection episode; the second (case 26) was obtained after treatment for the rejection. The two remaining transplant biopsy specimens displayed ischaemic damage (cases 25 and 27). Diagnosis of the 19 non-transplant biopsy specimens revealed a variety of renal lesions, including several glomerulonephritides, end stage renal failure, ischaemia, amyloidosis, diabetic glomerulosclerosis, and multiple myeloma.
Total tubular damage scores ranged from 0, in a case of membranous glomerulonephritis (case 20; fig 2) , to 25 in a patient with multiple myeloma (case 18; fig 3) . Usually, low tubular damage scores (1-7) were found in patients with membranous and mesangial proliferative glomerulonephritis.
LI/Tub ranged from 0 in patients with ischaemia (case 2), diabetic glomerulosclerosis (case 22), mesangial proliferative (case 7), membranous (case 20), and diffuse proliferative glomerulonephritis (case 21) to 3-68% in a transplanted kidney undergoing cellular rejection (case 8; fig 4) .
Analyses of variance showed highly significant correlations between the total tubular damage score and both Ll/Tub (fig 5A; Interestingly, the highest labelling was seen in a case of acute transplant rejection, and a subsequent biopsy specimen after treatment showed a considerably lower value. Consequently, further studies are concentrating specifically on BrdU labelling in renal transplant rejection. It has been agreed that invasion of tubules by lymphoid cells (tubulitis) is a better indicator of acute rejection than simple interstitial accumulation,14 although any differences in the activity of these lymphoid cells have yet to be identified. Cell proliferation with BrdU, together with phenotype studies, may clarify this issue, as the combined technique will distinguish actively rejecting populations from "inert" lymphoid cell collections.
